Patent details

EP3844189 Title: DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES

Basic Information

Publication number:
EP3844189
PCT Application Number:
US2019049027
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197828007
PCT Publication Number:
WO2020047389
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSING STRATEGY THAT MITIGATES CYTOKINE RELEASE SYNDROME FOR CD3/CD20 BISPECIFIC ANTIBODIES
French Title of Invention:
STRATÉGIE DE DOSAGE ATTÉNUANT LE SYNDROME DE LIBÉRATION DE CYTOKINE POUR LES ANTICORPS BISPÉCIFIQUE CD3 / CD20
German Title of Invention:
DOSIERSTRATEGIE, DIE DAS CYTOKIN-FREISETZUNGSSYNDROM FÜR CD3 / CD20-BISPECIFISCHE-ANTIKÖRPER VERMEIDET
SPC Number:

Dates

Filing date:
30/08/2019
Grant date:
22/01/2025
EP Publication Date:
07/07/2021
PCT Publication Date:
05/03/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/01/2025
EP B1 Publication Date:
22/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/08/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/01/2025
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
NLO
From:
24/01/2025
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
LOWY, Israel
Address:
United States (US)

2

Name:
ADRIAENS, Lieve Lucille
Address:
United States (US)

3

Name:
BROWNSTEIN, Carrie
Address:
United States (US)

Priority

1

Priority Number:
201862726137 P
Priority Date:
31/08/2018
Priority Country:
United States (US)

2

Priority Number:
201862774019 P
Priority Date:
30/11/2018
Priority Country:
United States (US)

3

Priority Number:
201962861100 P
Priority Date:
13/06/2019
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61K 31/573; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202504
Publication date:
22/01/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/07/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
24/01/2025 Power Of Attorney 1
24/01/2025 Outgoing Correspondence 1